Active	Status	Sponsor type	Region	Phase	Filter
7 Active 2 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fu, Wei M
AZUR-2, NCT05855200: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer	Recruiting	3	711	Europe, Canada, Japan, US, RoW	Dostarlimab, CAPEOX, FOLFOX	GlaxoSmithKline	Colonic Neoplasms, Neoplasms, Colon	12/28	12/30
NCT05745363: Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer	Recruiting	1/2	20	RoW	AL2846 capsule	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Differentiated Thyroid Cancer	06/24	12/24
NCT03943472: BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma	Recruiting	1	10	RoW	Anti-BCMA CAR-T cells, Fludarabine, Cyclophosphamide, Immune inhibitors	Hrain Biotechnology Co., Ltd., Shanghai Changzheng Hospital	Multiple Myeloma	11/21	05/22
NCT03716011: A Postmarket Clinical Trial for EXCROSSAL Stent in CAD Patients With 3-month DAPT or 12-month DAPT	Not yet recruiting	N/A	2700	RoW	EXCROSSAL	JW Medical Systems Ltd	Coronary Artery Disease	12/21	12/25